CHINA PHARMA HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 13.30 thousand shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-05-14
- CHINA PHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.30K shares, a 0.00% change year-over-year.
- CHINA PHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 13.30K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month |
|---|---|
| 2025-03-31 | 13.30K shares 10-Q · filed 2025-05-14 |
| 2024-03-31 | 13.30K shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |